What are the causes of macrocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Macrocytosis

The most common causes of macrocytosis include vitamin B12 deficiency, folate deficiency, alcoholism, medications, liver disease, and myelodysplastic disorders. 1

Classification of Macrocytosis

Macrocytosis is generally defined as a mean corpuscular volume (MCV) greater than 100 fL and can be divided into two main categories:

1. Megaloblastic Macrocytosis

  • Vitamin B12 deficiency

    • Most common cause of megaloblastic anemia 2
    • In Crohn's disease, prevalence ranges from 5.6-38% 3
    • Risk factors include:
      • Resection of >30 cm of distal ileum 3
      • Ileal involvement in Crohn's disease with >30-60 cm affected 3
  • Folate deficiency

    • Essential for nucleoprotein synthesis and normal erythropoiesis 4
    • Causes impaired thymidylate synthesis leading to defective DNA synthesis 4
    • Common in patients taking certain medications:
      • Sulfasalazine (causes folate malabsorption) 3
      • Methotrexate (inhibits dihydrofolate reductase) 3

2. Non-Megaloblastic Macrocytosis

  • Medications

    • Azathioprine and 6-mercaptopurine (through myelosuppressive activity) 3
    • Zidovudine (has become a leading cause in some populations) 5
  • Liver disease 1, 6

    • Typically presents with mild, uniform macrocytosis with round RBCs 6
  • Alcoholism 1, 5

  • Reticulocytosis 6

    • Due to hemolysis or hemorrhage
    • MCV rarely exceeds 110 fL 6
  • Hypothyroidism 1, 2

  • Myelodysplastic syndromes and myeloproliferative disorders 1, 7

    • Important consideration in unexplained macrocytosis
    • 11.6% of patients with unexplained macrocytosis develop primary bone marrow disorders 7
  • Multiple myeloma 3

Diagnostic Features

Laboratory Findings

  • Megaloblastic anemia:

    • MCV may exceed 150 fL 6
    • Peripheral smear shows macro-ovalocytes and hypersegmented neutrophils 1
    • RBCs vary considerably in size and shape 6
    • Macrocytes tend to be oval 6
  • Non-megaloblastic causes:

    • Liver disease: mild macrocytosis with round RBCs 6
    • Reticulocytosis: MCV rarely exceeds 110 fL 6

Diagnostic Approach

  1. Complete blood count with MCV measurement
  2. Peripheral blood smear to distinguish megaloblastic from non-megaloblastic causes
  3. Reticulocyte count to identify hemolysis or hemorrhage
  4. Vitamin B12 and folate levels:
    • Serum folate levels below 5 ng/mL indicate deficiency 4
    • Levels below 2 ng/mL usually result in megaloblastic anemia 4
  5. Liver function tests to identify liver disease
  6. Thyroid function tests to rule out hypothyroidism
  7. Medication review to identify drug-induced causes
  8. Bone marrow biopsy when cytopenias are present or macrocytosis remains unexplained 7

Management Considerations

  • For vitamin B12 deficiency:

    • In Crohn's disease with clinical deficiency: 1000 mg vitamin B12 IM every other day for a week, then monthly for life 3
    • For patients with >20 cm ileum resected: prophylactic 1000 mg vitamin B12 monthly indefinitely 3
  • For folate deficiency:

    • Patients on sulfasalazine or methotrexate should receive supplementation 3
    • For methotrexate users: 5 mg folate once weekly 24-72 hours after methotrexate, or 1 mg daily for 5 days per week 3
  • For unexplained macrocytosis:

    • Close follow-up with blood cell counting every 6 months 7
    • Consider bone marrow biopsy if cytopenias develop 7

Pitfalls and Caveats

  • Macrocytosis can occur with Epoetin therapy due to shifting of immature (large) reticulocytes into circulation 3
  • Iron overload can also be associated with macrocytosis 3
  • Unexplained macrocytosis requires vigilant monitoring as 11.6% of patients may develop primary bone marrow disorders within a median follow-up of 4 years 7
  • In patients with inflammatory conditions, standard cutoffs for deficiencies may not apply, and higher thresholds for diagnosis may be needed

References

Research

Evaluation of macrocytosis.

American family physician, 2009

Research

Anemia: Macrocytic Anemia.

FP essentials, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Changing etiology of macrocytosis. Zidovudine as a frequent causative factor.

American journal of clinical pathology, 1993

Research

Investigation of macrocytic anemia.

Postgraduate medicine, 1979

Research

Unexplained macrocytosis.

Southern medical journal, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.